Overview

Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children

Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the long-term safety of Adhansia XR in children and to characterize the pharmacokinetics (PK) in 4 to 5 year-olds.
Phase:
Phase 4
Details
Lead Sponsor:
Purdue Pharma LP